Thomas R. Staab II, Senior Vice President and CFO at BIOCRYST PHARMACEUTICALS INC (BCRX), sold 16,750 shares at $7.30 ($126K) on 2019-05-02, disclosed to the SEC on 2019-05-06.
Open-market sale of $126k BCRX by Senior Vice President and CFO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.30 | 7,750 | $57K | 44.8% |
| 2 | $7.75 | 9,000 | $70K | 55.2% |
| Total | $7.54 avg | 16,750 | $126K | 100% |
| Filing → |
| BCRX | SELL | 2019-05-16 | $92K | — | Filing → |
| BCRX | SELL | 2019-05-13 | $224K | — | Filing → |
| BCRX | SELL | 2019-04-08 | $66K | — | Filing → |